|  | 
  
    | 
		   
		         
    | 
          
		   |  | Recommended Results |  
              |  | 
       
      
      
       
      
         |  |   
		  | 公司介绍 |   
          |  | Silymarin≥80% (DAB 10) Silybinin ≥95%
 Ginsendosides≥ 10%-80%
 Schisandrin≥9%
 Polygoni multiflori P.E.
 Anthraqunones≥2%
 Epimedium herb P.E.
 Ganoderma P.E.
 Lentinus edodes P.E.
 Ginkgo Leaves Extract
 Tribulus Terrestris P.E.
 Green Tea P.E.
 Grape Seed P.E.
 Dong Quai P.E.
 Common Yam P.E.
 Puerariae P.E.
 Echinacea Herb P.E.
 Magnolia P.E.
 Horsetail P.E.
 Red clover P.E.
 Rhodiola                                         Siberian Ginseng P.E.
 Soybeam P.E.
 St.john’s wort P.E
 Ginger root extract
 Black cohosh P.E.
 Astragalus                                       Garlic powder
 Billberry P.E.
 Fenugreek extract
 Bitter Melon P.E                            semen cassiae p.e                           Lotus Leaf Extract
 Wolfberry P.E
 Aloe vera Extract
 hops flower extract
 Luo han kuo extract
 
 
 Resveratrol                           98%
 Tanshinone IIA                     90%
 Quercetin                              98%
 Oxymatrine                            98%
 Gypenosides                     98%
 Puerarin                              98%
 10-Hydroxycamptot            98%
 ellagic acid                          95%/98%
 5-HTP                                       99%
 Jujuboside  A                  2%-30%
 Luteolin                           98%
 Emodin                             50%
 
 |  
		  | 相关产品 |  |  | Ginseng extract/Milk thistle extract/silymarin |   
  		  | 公司基本资料 |   
          |  | 
                     
                      | 公司名称: | Panjin Huacheng Pharmaceutical Co., Ltd, xi'an office |   
                      | 连络: | 联络我们 |   
                      | 网址: | ******** ********
 |   
                      | 电话: | 86-29-8256683 |   
                     | 传真: | 86-29-88256682 |   
                      | 国家: | 中国 |   
                      | 住址: | Gaoxin Rd, xi'an , china |  |   
         
		   | 产品橱窗 |   
          |  |  |  |  |
 
        
   |